US Diabetes Market Report: 2016 - 2020



IMARC’s new report “US Diabetes Market Report: 2016 – 2020” comprehensively discusses the US diabetes market. With more than 27 Million diabetes patients in the US, it represented the world’s third largest diabetes patient pool in 2015. The prevailing cases of diabetes are largely due to rising obesity levels and an increasing aging population. It has been found in the report that more than half of the US population is either obese or overweight which is mainly due to their sedentary lifestyles, physical inactivities and unhealthy eating habits. Furthermore, the aging population in the US has been on the rise since the 1960’s. People aged 65 years and above accounted for around 9% of the total population in 1960 while in 2015, this age group accounted for around 15% of the entire US population. Driven by rising incidences of diabetes and the fact that the US has one of the highest per capita healthcare expenditures, the US market for diabetes drugs has grown at a CAGR of around 13.3% during 2008-2015, reaching a value of US$ 32,783 Million in 2015.

The report has provided analysis of the population and prevalence rates of diabetes on the basis of type, region, gender and age group. The report finds that compared to Type-1 diabetes, Type-2 diabetes represents the more prevalent type, accounting for the majority of all diagnosed diabetes cases. Based on regions, urban areas currently consist of the majority of the diabetes patients as compared to rural areas. Based on gender, females presently account for the majority of the total diabetes patients. In terms of age groups, the age group 40-59 currently accounts for the majority of the total diabetes patients in the US followed by the age group 60-79 and 20-39.

The report has further segmented the US diabetes market according to drug types. The market currently consists of insulin and oral anti-diabetics, with insulin accounting for the majority of the total sales. For each of the two drug types, the report has also provided historical market trends, market breakup by class, key players and market outlook. On the basis of class, Long Acting Insulin represent the biggest class in the insulin market while DPP-IV inhibitors represent the biggest class in the oral anti-diabetics market.

This report provides an analytical and statistical insight into the US diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in the United States. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the US diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the US diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the US diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in US
  • Historical, current and future prevalence of type-1 and type-2 diabetes in US
  • Historical, current and future prevalence of diabetes in the urban and rural regions in US
  • Historical, current and future prevalence of diabetes among males and females in US
  • Historical, current and future prevalence of diabetes among various age groups in US
  • Historical, current and future diagnosis rates for diabetes in US
  • Historical, current and future drug treatment rates for diabetes in US

Comprehensive situation analysis of the US Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in US
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the US Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in US
  • Performance of key classes
  • Performance of key players
  • Market outlook

1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications
4 Key Factors Driving the Diabetes Market in US
5 US Diabetes Epidemiology
5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
6 US Diabetes Market
6.1 Historical Market Trends
6.2 Market Outlook
6.3 Market Breakup by Segment
6.4 US Oral Antidiabetics Market
6.4.1 Historical Market Trends
6.4.2 Market Breakup by Class
6.4.3 Market Shares of Key Players
6.4.4 Market Outlook
6.5 US Insulin Market
6.5.1 Historical Market Trends
6.5.2 Market Breakup by Class
6.5.3 Market Shares of Key Players
6.5.4 Market Outlook

 

List of Figures

Figure 3 1: The impact of Diabetes in the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 & 2035
Figure 4 2: US: Overweight & Obese Population* (in Million), 2010, 2015 & 2020
Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 4 4: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
Figure 4 5: US: Diabetes Prevalence By Age Groups, (in %)
Figure 5 1: US: Total Number of Diabetes Patients* (in 000), 2008-2015
Figure 5 2: US: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020
Figure 5 3: US (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015
Figure 5 4: US (Type1 & Type2): Total Number of Diabetes Patients* (in 000),2016-2020
Figure 5 5: US (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2008 -2015
Figure 5 6: US (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Figure 5 7: US (Male & Female): Total Number of Diabetes Patients* (in 000), 2008 - 2015
Figure 5 8: US (Male & Female): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Figure 5 9: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2008 - 2015
Figure 5 10: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2016 - 2020
Figure 6 1: US: Diabetes Drugs Market (in Million US$), 2008 - 2015
Figure 6 2: US: Diabetes Drug Market Forecast (in Million US$), 2016 - 2020
Figure 6 3: US: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008- 2015
Figure 6 4: US: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016 - 2020
Figure 6 5: US: Oral Antidiabetics Market: (in Million US$), 2008 - 2015
Figure 6 6: US: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008 & 2015
Figure 6 7: US: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 6 8: US: Oral Antidiabetics Market: (in Million US$), 2016 - 2020
Figure 6 9: US: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 & 2020
Figure 6 10: US: Insulin Market, (in Million US$), 2008 - 2015
Figure 6 11: US: Breakup of Insulin Market by Class (in %)
Figure 6 12: US: Insulin Market: Sales Share of Key Players (in %)
Figure 6 13: US: Insulin Market Forecast (in Million US$), 2016 - 2020

 

List of Tables

Table 3 1: Diagnosis of Diabetes
Table 4 1: Global: Diabetes Population Breakup by Country (in 000’s), 2015 & 2035
Table 4 2: US: Overweight &Obesity Statistics, 2010, 2015 & 2020
Table 4 3: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
Table 5 1: US: Total Prevalence & Number of Diabetes Patients*, 2008, 2015 & 2020
Table 5 2: US (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 3: US (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 4: US (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2008, 2015 & 2020


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Global Biopharmaceutical Manufacturing Market Report 2016-2021

IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2016-2021” provides a detailed analysis on the global biopharmaceutical manufacturing industry. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compar...


Global Biopharmaceutical Market Report & Forecast (2016-2021)

IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2016-2021)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market tre...


Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2016-2021)

The new report from IMARC group entitled ‘Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2008-2021)’ maps out a comprehensive analysis o...


Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

The report entitled “Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand...


Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

The report entitled “Japan Generic Drug Market: Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Japan. This research report serves as an exceptional tool to understand th...